Click to view 3D structure | Sigma non-opioid intracellular receptor 1 | Q99720 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.368
- Applicability Domain
- 0.478
- Statistical Significance
- 0.0197
- Supporting Reference Compounds
- 562
- E-value
- 153.207
|
Click to view 3D structure | D(1A) dopamine receptor | P18901 | Rattus norvegicus | Predicted (SEA) | - Prediction Confidence Score
- 0.332
- Applicability Domain
- 0.478
- Statistical Significance
- 0.0133
- Supporting Reference Compounds
- 206
- E-value
- 103.695
|
Click to view 3D structure | 5-hydroxytryptamine receptor 6 | P50406 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.295
- Applicability Domain
- 0.412
- Statistical Significance
- 0.0508
- Supporting Reference Compounds
- 536
- E-value
- 395.63
|
Click to view 3D structure | Delta-type opioid receptor | P41143 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.284
- Applicability Domain
- 0.478
- Statistical Significance
- 0.0757
- Supporting Reference Compounds
- 427
- E-value
- 589.63
|
Click to view 3D structure | Voltage-gated inwardly rectifying potassium channel KCNH2 | Q12809 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.28
- Applicability Domain
- 0.347
- Statistical Significance
- 0.2692
- Supporting Reference Compounds
- 1498
- E-value
- 2095.78
|
Click to view 3D structure | 5-hydroxytryptamine receptor 1A | P19327 | Rattus norvegicus | Predicted (SEA) | - Prediction Confidence Score
- 0.274
- Applicability Domain
- 0.347
- Statistical Significance
- 0.0972
- Supporting Reference Compounds
- 541
- E-value
- 756.617
|
Click to view 3D structure | D(2) dopamine receptor | P14416 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.273
- Applicability Domain
- 0.347
- Statistical Significance
- 0.1651
- Supporting Reference Compounds
- 1103
- E-value
- 1285.13
|
Click to view 3D structure | 5-hydroxytryptamine receptor 7 | P34969 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.271
- Applicability Domain
- 0.347
- Statistical Significance
- 0.1003
- Supporting Reference Compounds
- 565
- E-value
- 780.516
|
Click to view 3D structure | Alpha-2A adrenergic receptor | P08913 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.268
- Applicability Domain
- 0.347
- Statistical Significance
- 0.0969
- Supporting Reference Compounds
- 487
- E-value
- 754.67
|
Click to view 3D structure | Protein deacetylase HDAC6 | Q9UBN7 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.264
- Applicability Domain
- 0.412
- Statistical Significance
- 0.1856
- Supporting Reference Compounds
- 553
- E-value
- 1444.57
|
Click to view 3D structure | 5-hydroxytryptamine receptor 1A | P08908 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.263
- Applicability Domain
- 0.347
- Statistical Significance
- 0.1835
- Supporting Reference Compounds
- 953
- E-value
- 1428.92
|
Click to view 3D structure | 5-hydroxytryptamine receptor 2A | P28223 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.262
- Applicability Domain
- 0.347
- Statistical Significance
- 0.2117
- Supporting Reference Compounds
- 955
- E-value
- 1648.07
|
Click to view 3D structure | 5-hydroxytryptamine receptor 2C | P28335 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.261
- Applicability Domain
- 0.347
- Statistical Significance
- 0.1942
- Supporting Reference Compounds
- 823
- E-value
- 1511.6
|
Click to view 3D structure | D(3) dopamine receptor | P35462 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.26
- Applicability Domain
- 0.347
- Statistical Significance
- 0.193
- Supporting Reference Compounds
- 861
- E-value
- 1502.65
|
Click to view 3D structure | Pleiotropic ABC efflux transporter of multiple drugs | P33302 | Saccharomyces cerevisiae S288c | Predicted (SEA) | - Prediction Confidence Score
- 0.26
- Applicability Domain
- 0.347
- Statistical Significance
- 0.0013
- Supporting Reference Compounds
- 10
- E-value
- 9.9647
|
Click to view 3D structure | D(4) dopamine receptor | P21917 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.258
- Applicability Domain
- 0.347
- Statistical Significance
- 0.1618
- Supporting Reference Compounds
- 524
- E-value
- 1259.44
|
Click to view 3D structure | Potassium channel subfamily K member 2 | O95069 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.257
- Applicability Domain
- 0.478
- Statistical Significance
- 0.0017
- Supporting Reference Compounds
- 21
- E-value
- 13.4679
|
Click to view 3D structure | D(1A) dopamine receptor | P21728 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.256
- Applicability Domain
- 0.347
- Statistical Significance
- 0.1203
- Supporting Reference Compounds
- 425
- E-value
- 936.37
|
Click to view 3D structure | D(2) dopamine receptor | P61169 | Rat | Predicted (SEA) | - Prediction Confidence Score
- 0.256
- Applicability Domain
- 0.276 Low confidence
- Statistical Significance
- 0.148
- Supporting Reference Compounds
- 528
- E-value
- 1151.86
|
Click to view 3D structure | Muscarinic acetylcholine receptor M1 | P11229 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.253
- Applicability Domain
- 0.347
- Statistical Significance
- 0.1307
- Supporting Reference Compounds
- 385
- E-value
- 1017.26
|
Click to view 3D structure | Muscarinic acetylcholine receptor M2 | P08172 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.253
- Applicability Domain
- 0.347
- Statistical Significance
- 0.1251
- Supporting Reference Compounds
- 373
- E-value
- 973.738
|
Click to view 3D structure | Muscarinic acetylcholine receptor M4 | P08173 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.253
- Applicability Domain
- 0.347
- Statistical Significance
- 0.098
- Supporting Reference Compounds
- 297
- E-value
- 762.845
|
Click to view 3D structure | Alpha-1A adrenergic receptor | P43140 | Rattus norvegicus | Predicted (SEA) | - Prediction Confidence Score
- 0.252
- Applicability Domain
- 0.347
- Statistical Significance
- 0.0776
- Supporting Reference Compounds
- 208
- E-value
- 604.266
|
Click to view 3D structure | Muscarinic acetylcholine receptor M3 | P20309 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.251
- Applicability Domain
- 0.347
- Statistical Significance
- 0.1105
- Supporting Reference Compounds
- 310
- E-value
- 860.39
|
Click to view 3D structure | Histamine H1 receptor | P35367 | Humans | Predicted (SEA) | - Prediction Confidence Score
- 0.251
- Applicability Domain
- 0.347
- Statistical Significance
- 0.188
- Supporting Reference Compounds
- 507
- E-value
- 1463.25
|
Click to view 3D structure | D(2) dopamine receptor | P14416 | Humans | Known | Flupenthixol is a thioxanthene antipsychotic. The mechanism of action of Flupenthixol is not completely understood. Flupenthixol is a powerful antagonist of both D1 and D2 dopamine receptors, and an alpha-adrenergic receptor antagonist. It's antipsychotic activity is thought to be related to blocks postsynaptic dopamine receptors in the CNS. |
Click to view 3D structure | ATP-dependent translocase ABCB1 | P08183 | Humans | Known | Flupenthixol is a thioxanthene antipsychotic. The mechanism of action of Flupenthixol is not completely understood. Flupenthixol is a powerful antagonist of both D1 and D2 dopamine receptors, and an alpha-adrenergic receptor antagonist. It's antipsychotic activity is thought to be related to blocks postsynaptic dopamine receptors in the CNS. |
Click to view 3D structure | D(1A) dopamine receptor | P21728 | Humans | Known | Flupenthixol is a thioxanthene antipsychotic. The mechanism of action of Flupenthixol is not completely understood. Flupenthixol is a powerful antagonist of both D1 and D2 dopamine receptors, and an alpha-adrenergic receptor antagonist. It's antipsychotic activity is thought to be related to blocks postsynaptic dopamine receptors in the CNS. |
Click to view 3D structure | Alpha-1A adrenergic receptor | P35348 | Humans | Known | Flupenthixol is a thioxanthene antipsychotic. The mechanism of action of Flupenthixol is not completely understood. Flupenthixol is a powerful antagonist of both D1 and D2 dopamine receptors, and an alpha-adrenergic receptor antagonist. It's antipsychotic activity is thought to be related to blocks postsynaptic dopamine receptors in the CNS. |
Click to view 3D structure | 5-hydroxytryptamine receptor 2A | P28223 | Humans | Known | Not Available |
Click to view 3D structure | Muscarinic acetylcholine receptor M1 | P11229 | Humans | Known | Not Available |
Click to view 3D structure | Neuron-specific vesicular protein calcyon | Q9NYX4 | Humans | Known | Flupenthixol is a thioxanthene antipsychotic. The mechanism of action of Flupenthixol is not completely understood. Flupenthixol is a powerful antagonist of both D1 and D2 dopamine receptors, and an alpha-adrenergic receptor antagonist. It's antipsychotic activity is thought to be related to blocks postsynaptic dopamine receptors in the CNS. |
Click to view 3D structure | Sigma non-opioid intracellular receptor 1 | Q99720 | Humans | Known | Not Available |